Surgery Websites
Transplant Surgery »  Meet the Team »  Hepatology »  Danielle Brandman, M.D., M.A.S.
Danielle Brandman, M.D., M.A.S.

Danielle Brandman, M.D., M.A.S.

Assistant Professor of Medicine
Hepatology and Liver Transplantation
Department of Medicine

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
(415) 514-1094 - Phone
(415) 476-0659 - Fax
Open Popup

Boston University, B.A., Biology and Psychology, 1995-1999

UMDNJ-New Jersey Medical School, M.D., 2001-2005

University of California, San Francisco, M.A.S., Clinical Research, 2009-2011

  • University of California, San Francisco, Intern, Medicine, 2005-2006
  • University of California, San Francisco, Resident, Medicine, 2006-2008
  • University of California, San Francisco, Fellow, Gastroenterology, 2008-2011
  • University of California, San Francisco, Fellow, Transplant Hepatology, 2011-2012
  • American Board of Internal Medicine
  • American Board of Internal Medicine - Gastroenterology
  • UCSF Liver Center
  • Hepatitis C virus (HCV)
  • Liver injury and repair (Liver transplantation)
  • Nonalcoholic steatohepatitis (NASH)

Dr. Danielle Brandman is an Assistant Professor of Medicine and hepatologist, specializing in treating patients needing liver transplants. Her research interests include nonalcoholic fatty liver disease and post-transplant metabolic syndrome.  She engages in outcomes-based research with a special interest in NAFLD and liver transplantation: the post-transplant outcomes of patients with NAFLD, selection of patients with NAFLD for transplant, recurrence of NAFLD following transplant, and new-onset NAFLD after liver transplantation for other causes of liver disease

Dr. Brandman received her medical degree at UMDNJ New Jersey Medical School in 2005. She continued her medical training at University of California, San Francisco, where she completed her residency, gastroenterology fellowship, transplant hepatology fellowship, and master's degree in clinical research. Dr. Brandman is certified by the American Board of Internal Medicine in internal medicine and gastroenterology.  She is a member of the American Association for the Study of Liver Disease (AASLD).

  Confired By    
  • Resident Mentor of the Year
  • CTSI Resident Research Program
  • 2016
  • Haile T. Debas Academy of Medical Educators, Excellence in Teaching Award
  • UCSF
  • 2015
    Data provided by UCSF Profiles, powered by CTSI
    1. Campos-Varela I, Dodge JL, Terrault NA, Brandman D, Price JC. Non-viral Liver Disease is the Leading Indication for Liver Transplant in the U.S. in Persons Living with Human Immunodeficiency Virus. Am J Transplant. 2021 Mar 22. View in PubMed
    2. Danielle Brandman. Obesity Management of Liver Transplant Waitlist Candidates and Recipients. Clinics in Liver Disease. 2021 Feb 1; 25(1):1-18. View in PubMed
    3. Bond AR, Bainbridge E, Doernberg SB, Babik JM, Miller S, Khanafshar E, Henry T, David A, Russell M, Brandman D, Sherman CB, Yao F, Fung M. Disseminated Legionella micdadei Infection in a Liver Transplant Patient Presenting as Pulmonary Nodules and a Laryngeal Lesion. Transpl Infect Dis. 2021 Jan 12; e13563. View in PubMed
    4. Xu CQ, Zhou K, Brandman D. The Updated US Preventive Services Task Force Hepatitis B Screening Recommendations-Staying Committed. JAMA Intern Med. 2020 Dec 15. View in PubMed
    5. Price JC, Brandman D. Updated Hepatitis C Virus Screening Recommendation-A Step Forward. JAMA Intern Med. 2020 05 01; 180(5):637-639. View in PubMed
    6. View All Publications


    Site Directory